{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:39:52Z","timestamp":1792690792156,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":371,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100030715","name":"Hillman Cancer Center, Medical Center, University of Pittsburgh","doi-asserted-by":"publisher","award":["P30CA047904-35"],"award-info":[{"award-number":["P30CA047904-35"]}],"id":[{"id":"10.13039\/100030715","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5F30CA264963-04"],"award-info":[{"award-number":["5F30CA264963-04"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ymthe.2025.03.042","type":"journal-article","created":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T16:55:51Z","timestamp":1743094551000},"page":"2229-2237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Immuno-oncology recapitulates ontogeny: Modern cell and gene therapy for cancer"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6985-7510","authenticated-orcid":false,"given":"Neil","family":"Carleton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron B.I.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jishnu","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Lotze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.03.042_bib1","article-title":"Arginase-1-specific T\u00a0cells target and modulate tumor-associated macrophages","volume":"13","author":"Martinenaite","year":"2025","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2025.03.042_bib2","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1038\/s41388-020-01624-1","article-title":"Onco-ontogeny recapitulates phylogeny - a consideration","volume":"40","author":"Plowman","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.ymthe.2025.03.042_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0160-9327(78)90030-3","article-title":"Towards the clinical use of interferon","volume":"2","author":"Cantell","year":"1978","journal-title":"Endeavour"},{"key":"10.1016\/j.ymthe.2025.03.042_bib4","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.4049\/jimmunol.135.4.2865","article-title":"In\u00a0vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in\u00a0vivo with recombinant IL 2","volume":"135","author":"Lotze","year":"1985","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2025.03.042_bib5","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDe2200264","article-title":"An Interleukin-15 Superagonist with BCG - A Major Therapeutic Advancement or Just a Small Step in the Right Direction?","volume":"2","author":"Pietzak","year":"2023","journal-title":"NEJM Evid."},{"key":"10.1016\/j.ymthe.2025.03.042_bib6","article-title":"Tumor evasion from T\u00a0cell surveillance","volume":"2011","author":"T\u00f6pfer","year":"2011","journal-title":"J.\u00a0Biomed. Biotechnol."},{"key":"10.1016\/j.ymthe.2025.03.042_bib7","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/s41586-024-07661-0","article-title":"Interactions between immune cell types facilitate the evolution of immune traits","volume":"632","author":"Dubovik","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.03.042_bib8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41540-022-00224-x","article-title":"Mapping the epithelial-immune cell interactome upon infection in the gut and the upper airways","volume":"8","author":"Poletti","year":"2022","journal-title":"NPJ Syst. Biol. Appl."},{"key":"10.1016\/j.ymthe.2025.03.042_bib9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41392-024-01767-7","article-title":"The two sides of chromosomal instability: drivers and brakes in cancer","volume":"9","author":"Hosea","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2025.03.042_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1462496","article-title":"Genomic instability as a driver and suppressor of anti-tumor immunity","volume":"15","author":"Requesens","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2025.03.042_bib11","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1093\/bioinformatics\/btab086","article-title":"Multi-layered network-based pathway activity inference using directed random walks: application to predicting clinical outcomes in urologic cancer","volume":"37","author":"Kim","year":"2021","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ymthe.2025.03.042_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btad643","article-title":"Explainable Multilayer Graph Neural Network for cancer gene prediction","volume":"39","author":"Chatzianastasis","year":"2023","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ymthe.2025.03.042_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1600200","article-title":"Fundamentals of cancer metabolism","volume":"2","author":"DeBerardinis","year":"2016","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ymthe.2025.03.042_bib14","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1021\/acschembio.4c00312","article-title":"A Chemical Approach to Assess the Impact of Post-translational Modification on MHC Peptide Binding and Effector Cell Engagement","volume":"19","author":"Kelly","year":"2024","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ymthe.2025.03.042_bib15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s13721-022-00406-x","article-title":"Temporal networks in biology and medicine: a survey on models, algorithms, and tools","volume":"12","author":"Hosseinzadeh","year":"2023","journal-title":"Netw. Model. Anal. Health Inform. Bioinform."},{"key":"10.1016\/j.ymthe.2025.03.042_bib16","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1093\/bioinformatics\/btw310","article-title":"Exploring the structure and function of temporal networks with dynamic graphlets","volume":"32","author":"Hulovatyy","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ymthe.2025.03.042_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061326","article-title":"Understanding Immune Evasion and Therapeutic Targeting Associated with PD-1\/PD-L1 Pathway in Diffuse Large B-cell Lymphoma","volume":"20","author":"Song","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2025.03.042_bib18","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/cas.16045","article-title":"CD40 is expressed in the subsets of endothelial cells undergoing partial endothelial-mesenchymal transition in tumor microenvironment","volume":"115","author":"Takahashi","year":"2024","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ymthe.2025.03.042_bib19","article-title":"Dendritic cell-intrinsic PTPN22 negatively regulates antitumor immunity and impacts anti-PD-L1 efficacy","volume":"12","author":"Acero-Bedoya","year":"2024","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2025.03.042_bib20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.coi.2014.01.004","article-title":"New insights into cancer immunoediting and its three component phases--elimination, equilibrium and escape","volume":"27","author":"Mittal","year":"2014","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.ymthe.2025.03.042_bib21","doi-asserted-by":"crossref","first-page":"5154","DOI":"10.1038\/s41467-024-49106-2","article-title":"Progressive senescence programs induce intrinsic vulnerability to aging-related female breast cancer","volume":"15","author":"Bai","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.03.042_bib22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41568-019-0222-9","article-title":"How the ageing microenvironment influences tumour progression","volume":"20","author":"Fane","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ymthe.2025.03.042_bib23","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1158\/2326-6066.CIR-21-0804","article-title":"Insights into Immune Escape During Tumor Evolution and Response to Immunotherapy Using a Rat Model of Breast Cancer","volume":"10","author":"Gil Del Alcazar","year":"2022","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ymthe.2025.03.042_bib24","article-title":"Systemic and local chronic inflammation and hormone disposition promote a tumor-permissive environment for breast cancer in older women","author":"Carleton","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.ymthe.2025.03.042_bib25","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s43587-024-00751-8","article-title":"Comprehensive single-cell aging atlas of healthy mammary tissues reveals shared epigenomic and transcriptomic signatures of aging and cancer","volume":"5","author":"Angarola","year":"2025","journal-title":"Nat. Aging"},{"key":"10.1016\/j.ymthe.2025.03.042_bib26","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/j.ccell.2024.09.002","article-title":"Midkine as a driver of age-related changes and increase in mammary tumorigenesis","volume":"42","author":"Yan","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ymthe.2025.03.042_bib27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1158\/2159-8290.CD-22-0475","article-title":"The Great Immune Escape: Understanding the Divergent Immune Response in Breast Cancer Subtypes","volume":"13","author":"Onkar","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ymthe.2025.03.042_bib28","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1016\/S2666-7568(21)00280-4","article-title":"Personalising therapy for early-stage oestrogen receptor-positive breast cancer in older women","volume":"3","author":"Carleton","year":"2022","journal-title":"Lancet Healthy Longev."},{"key":"10.1016\/j.ymthe.2025.03.042_bib29","doi-asserted-by":"crossref","first-page":"e663","DOI":"10.1016\/S2666-7568(21)00179-3","article-title":"Is cancer biology different in older patients?","volume":"2","author":"Van Herck","year":"2021","journal-title":"Lancet Healthy Longev."},{"key":"10.1016\/j.ymthe.2025.03.042_bib30","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1200\/JCO.21.02170","article-title":"Breast Cancers Are Immunogenic: Immunologic Analyses and a Phase II Pilot Clinical Trial Using Mutation-Reactive Autologous Lymphocytes","volume":"40","author":"Zacharakis","year":"2022","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ymthe.2025.03.042_bib31","article-title":"Art of TIL immunotherapy: SITC's perspective on demystifying a complex treatment","volume":"13","author":"Turcotte","year":"2025","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2025.03.042_bib32","article-title":"Utilization of primary tumor samples for cancer neoantigen discovery","volume":"13","author":"Leko","year":"2025","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2025.03.042_bib33","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/s41586-024-07135-3","article-title":"SOX17 enables immune evasion of early colorectal adenomas and cancers","volume":"627","author":"Goto","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.03.042_bib34","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1158\/2159-8290.CD-17-1327","article-title":"Genetic Mechanisms of Immune Evasion in Colorectal Cancer","volume":"8","author":"Grasso","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ymthe.2025.03.042_bib35","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41698-023-00488-4","article-title":"Profiling the heterogeneity of colorectal cancer consensus molecular subtypes using spatial transcriptomics","volume":"8","author":"Valdeolivas","year":"2024","journal-title":"NPJ Precis. Oncol."},{"key":"10.1016\/j.ymthe.2025.03.042_bib36","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/nm.3967","article-title":"The consensus molecular subtypes of colorectal cancer","volume":"21","author":"Guinney","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.03.042_bib37","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1038\/s41467-022-29027-8","article-title":"Immunosuppressive niche engineering at the onset of human colorectal cancer","volume":"13","author":"Gatenbee","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.03.042_bib38","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1609279","article-title":"T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer","volume":"375","author":"Tran","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.03.042_bib39","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41586-019-1032-7","article-title":"Neoantigen-directed immune escape in lung cancer evolution","volume":"567","author":"Rosenthal","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.03.042_bib40","article-title":"Tumor resistance to anti-mesothelin CAR-T cells caused by binding to shed mesothelin is overcome by targeting a juxtamembrane epitope","volume":"121","author":"Liu","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.03.042_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17010035","article-title":"Engineered Cellular Therapies for the Treatment of Thoracic Cancers","volume":"17","author":"Erickson","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ymthe.2025.03.042_bib42","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1038\/s41467-023-38841-7","article-title":"In\u00a0vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancer","volume":"14","author":"Dervovic","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.03.042_bib43","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.ucl.2020.10.004","article-title":"Immune Escape in Prostate Cancer: Known and Predicted Mechanisms and Targets","volume":"47","author":"Reva","year":"2020","journal-title":"Urol. Clin. North Am."},{"key":"10.1016\/j.ymthe.2025.03.042_bib44","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1016\/j.cell.2023.05.028","article-title":"DNA hypomethylation silences anti-tumor immune genes in early prostate cancer and CTCs","volume":"186","author":"Guo","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2025.03.042_bib45","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41467-023-36325-2","article-title":"Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses","volume":"14","author":"Hirz","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.03.042_bib46","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/pros.24068","article-title":"High intratumoral CD8(+) T-cell infiltration is associated with improved survival in prostate cancer patients undergoing radical prostatectomy","volume":"81","author":"Yang","year":"2021","journal-title":"Prostate"},{"key":"10.1016\/j.ymthe.2025.03.042_bib47","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41586-020-2229-5","article-title":"Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I","volume":"581","author":"Yamamoto","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.03.042_bib48","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.ccell.2020.08.004","article-title":"Challenges and Opportunities for Pancreatic Cancer Immunotherapy","volume":"38","author":"Bear","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ymthe.2025.03.042_bib49","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41586-022-04735-9","article-title":"Neoantigen quality predicts immunoediting in survivors of pancreatic cancer","volume":"606","author":"\u0141uksza","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.03.042_bib50","article-title":"Transient lymphocyte count decrease correlates with oncolytic adenovirus efficacy in humans: mechanistic and biomarker findings from TUNIMO phase I trial","volume":"13","author":"Pakola","year":"2025","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2025.03.042_bib51","article-title":"Engineered oncolytic virus expressing B7H3-targeting BiTE enhances antitumor T-cell immune response","volume":"12","author":"Zhu","year":"2024","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2025.03.042_bib52","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41585-023-00739-w","article-title":"Vaccines as treatments for prostate cancer","volume":"20","author":"Rastogi","year":"2023","journal-title":"Nat. Rev. Urol."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625002163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625002163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:42:49Z","timestamp":1792687369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625002163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1525001625002163"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.03.042","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immuno-oncology recapitulates ontogeny: Modern cell and gene therapy for cancer","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.03.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}